Objetivo
Mutations in the p53 tumor suppressor gene are the most frequent genetic alteration in human cancer, occurring in over 40% of all cases of cancer. One well-studied outcome of these mutations is the loss of the tumor suppressor activity of the wild type (wt) p53. However, there is growing evidence that many of the mutations that occur in the p53 protein in fact generate mutant p53 proteins (mutp53) that have acquired new biochemical and biological properties. Through this gain of function (GOF), mutp53 is believed to contribute actively to the cancer process. We propose to explore mutp53 as a target for novel anti-cancer therapies. Such therapies should aim to either abrogate the GOF effects of mutp53, or restore wt-like properties to mutp53, so that it can now regain its tumor suppressor capabilities. To achieve these ambitious aims, we propose a multi- disciplinary approach to explore and exploit the contribution of mutp53 to cancer. One component of this project will investigate in depth the molecular properties of mutp53: structural studies will pinpoint the changes that particular mutations inflict on the structure of p53, and allow the classification of mutp53 into distinct subclasses. In parallel, biochemical studies will explore the mode of action of mutp53 within cells, including its impact on patterns of gene expression, identification of specific DNA sequences targeted by mutp53, and discovery of mutp53-interacting cellular proteins. Preclinical models for mutpS 3-driven cancer will also be developed, as a critical instrument for pre- clinical studies. The other component will aim at translating this wealth of information into better cancer therapy. One part ofthat effort will address the clinical relevance of particular p53 mutations in human cancer, and particularly its impact on the patient s response to chemotherapy. This should lead to guidelines for more effective use of conventional therapy.#
Ámbito científico
- medical and health sciencesmedical biotechnologygenetic engineeringgene therapy
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- natural sciencesbiological sciencesgeneticsmutation
- medical and health sciencesclinical medicineoncology
- natural scienceschemical sciencesorganic chemistryamines
Palabras clave
Convocatoria de propuestas
FP6-2002-LIFESCIHEALTH
Consulte otros proyectos de esta convocatoria
Régimen de financiación
IP - Integrated ProjectCoordinador
STOCKHOLM
Suecia